483
National Cancer Institute Central IRBNational Cancer Institute Central IRB – FDA 483, Aug 9, 2022
Record Details
An FDA inspection of the National Cancer Institute Central IRB in Rockville, MD, revealed a significant procedural lapse. The Institutional Review Board failed to update its registration information regarding changes in chairperson within the required 90-day timeframe. This resulted in delays of 467 and 106 days for two separate IRB committees.
View Company Profile
ID · 34541808-bed8-418e-862d-d3b4628a3d0b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.